Document is current
Any future updates will be listed below
-
Authors
Zhang, Ting
Xiang, Mingfei
Yin, Hailin
Dan, Jiaqiang
Zu, Ruiling
Rao, Lubei
Zhang, Peiying
Wang, Yuan
Yang, Ran
Zhang, Yun
Luo, Huaichao
- License Information
-
More Information
Article History
Received: 16 August 2024
Accepted: 10 December 2024
First Online: 7 January 2025
Declarations
:
: The authors declare no competing interests.
: The research related to human use has complied with all the relevant national regulations, institutional policies and follows the tenets of the Helsinki Declaration, and has been approved by the Institutional Ethics Committee of The Sichuan Cancer Hospital and Chengdu Fifth People’s Hospital. The Institutional Review Board (IRB) of the Sichuan Cancer Hospital approved this retrospective study (IRB code: SCCHEC-02-2021-064 ). The Institutional Review Board (IRB) of Chengdu Fifth People’s Hospital approved this retrospective study (IRB code: Ethical review 2023-036(science)-01). This retrospective study has been approved to waive informed consent by the Institutional Review Board of the Sichuan Cancer Hospital and Chengdu Fifth People’s Hospital.
: The study was a retrospective analysis and didn’t require the patient’s informed consent.
